Primary biliary cholangitis (PBC) is a disease characterized by autoimmune destruction of small bile ducts, thereby preventing bile mobilization and increasing hepatic bile content. These symptoms…
This folder covers DRG’s Company & Drugs (C&D) data for Transplants which include market forecast (US, ROW and Global) and analysis on drug profie, drug group and therapy area.
Gout is a chronic condition characterized by intermittent acute flares caused by elevated serum uric acid (sUA). Treatment of the painful acute flares is distinct from the chronic management of…
Idiopathic pulmonary fibrosis (IPF) is an orphan disease affecting approximately 50,000 people in the United States. It is characterized by an irreversible loss of lung function, leading to high…
Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract characterized by diarrhea, abdominal pain, and weight loss. The primary goal of CD treatment is to induce and…
Like other retinal disease therapy markets, the retinal vein occlusion (RVO) with macular edema (ME) market in the United States is unique in that it is dominated by Genentech’s Avastin, an…
DRG Epidemiology's coverage of acute myeloid leukemia comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence…
The number of incident cases of AML in the countries under study will increase by 43%, from 58,000 to 82,000, in ten years. Of the countries considered in this analysis, the incidence of AML is…
The number of incident cases of AML in the Asia-Pacific countries under study will increase by 36%, from 10,500 to 14,200, in ten years. Of the countries considered in this analysis, the…
The number of incident cases of AML in the countries under study will increase by 33%, from 3,866 to 5,116, in ten years. Of the countries considered in this analysis, the incidence of AML is…
Clarivate Epidemiology’s coverage of chronic myeloid leukemia (CML) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…
The number of incident cases of AML in the countries under study will increase by 38%, from 3,150 to 4,300, in ten years. Of the countries considered in this analysis, the incidence of AML is…
Clarivate Epidemiology’s coverage of chronic myeloid leukemia (CML) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…
The number of incident cases of AML in the European countries under study will increase by 18%, from 5,876 to 6,932, in ten years. Of the countries considered in this analysis, the incidence of…
Clarivate Epidemiology’s coverage of chronic myeloid leukemia (CML) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…